Position in ARQT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$54,139,536
-$1,038,902 QoQ
Shares Held
2,297,943
+20.9% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 99.86914383864178.ToString("F0")%
Shared 0.ToString("F0")%
None 0.13085616135822342.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,629,017 across 165 Biotechnology names. ARQT ranks #27 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in ARQT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,139,536 | 2,297,943 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $55,178,438 | 1,900,084 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $43,562,708 | 2,311,019 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $38,313,532 | 2,732,777 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $43,194,035 | 2,761,767 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $46,098,812 | 3,309,319 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $39,528,887 | 4,250,418 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $41,275,064 | 4,438,179 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $46,006,778 | 4,642,460 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $15,037,407 | 4,655,544 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $6,862,393 | 1,292,353 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,748,667 | 1,652,536 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,527,070 | 1,593,370 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,806,492 | 797,736 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $15,268,813 | 798,996 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,917,923 | 793,896 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $12,708,441 | 659,836 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,770,550 | 615,745 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,741,719 | 575,208 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $15,711,617 | 575,728 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $18,891,521 | 653,008 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||